Comprehensive Analysis of CMV-specific T cells in Human Subjects Receiving a Replication-defective Human Cytomegalovirus Vaccine

Project: Research project

Project Details

StatusFinished
Effective start/end date8/28/188/27/22

Funding

  • Merck Sharp and Cohme Corporation: $5,000.00